Curcumin Recruiting Phase 2 Trials for Mild Cognitive Impairment (MCI) Prevention

IndicationsStatusPurposePhase
RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT01811381Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease